Randomized Phase II Trial of Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Enzalutamide (Primary) ; Fulvestrant (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 09 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 30 Sep 2017.
- 06 Jul 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jul 2017.
- 10 Jun 2017 Biomarkers information updated